Price to Earning ratio Analysis of Acasti Pharma Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY PE
Period Ending - Mar-23
Very Poor PE
-0.389
Period Ending - Mar-22
Very Poor PE
-1.68
Growth
76.86 %
Trailing Twelve Months PE
Period Ending - Mar-23
Very Poor PE
-149.97
PE Analysis of Acasti Pharma Inc
| P/E Ratio -149.97 of Acasti Pharma Inc is negative because of negative EPS. |
| PE Ratio of ACST rose handsomely by 76.86 % this year. |
| PE Ratio with value of -0.069 was highest in Year Mar-19 in last Five Years. |
| PE Ratio with value of -1.68 was lowest in Year Mar-22 in last Five Years. |
| Latest PE Ratio with value of -0.389 is Greater than Average PE of -0.510 in last five years. |
Other PE Related Info of ACST that may interest you.
Acasti Pharma Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| ACST | 2.69 | 2.7599 | 2.53 % | Biotechnology |
Defination of Price to Earning
PE Ratio measures the relationship between the company's current stock price and EPS (Earnings Per Share). PE Ratio indicates how many times investors pay money to get 1 rupee of return. It is one of the important parameters to evaluate whether a company's stock price is overvalued or undervalued. more ..
PE Related Ratios
| PriceToSalesRatio | PriceToBookRatio | PriceToCashFlowRatio |
Tsr Value Index
| Poor Value Stock | |
FY - Historical Price to Earning of Acasti Pharma Inc
| Period | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|
| PE | -0.389 | -1.68 | -0.233 | -0.178 | -0.069 | -0.058 | -0.118 |
| Change | 76.86 % | -620.72 % | -31.13 % | -156.60 % | -19.93 % | 50.86 % | 55.02 % |
FY Chart of Price to Earning of Acasti Pharma Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)